HemaSphere
(Aug 2023)
P1368: NKG2A DELETION IN HUMAN NATURAL KILLER CELLS ENHANCES ANTI-TUMOR RESPONSES AND PROMOTES TUMOR INFILTRATION
- Ying Gong,
- Wilfred Germeraad,
- Bo LI,
- Xulin Zhang,
- Lynn Janssen,
- Zongzong He,
- Bodeng Wu,
- Birgit Gijsbers,
- Timo Olieslagers,
- Gerard Bos,
- Lei Zheng,
- Roel Klein Wolterink
Affiliations
- Ying Gong
- 1 Maastricht University, Internal medicine, Tumor Immunology laboratory, Maastricht, The Netherlands
- Wilfred Germeraad
- 1 Maastricht University, Internal medicine, Tumor Immunology laboratory, Maastricht, The Netherlands
- Bo LI
- 2 Nanfang Hospital, Guang Zhou, China
- Xulin Zhang
- 2 Nanfang Hospital, Guang Zhou, China
- Lynn Janssen
- 1 Maastricht University, Internal medicine, Tumor Immunology laboratory, Maastricht, The Netherlands
- Zongzong He
- 2 Nanfang Hospital, Guang Zhou, China
- Bodeng Wu
- 2 Nanfang Hospital, Guang Zhou, China
- Birgit Gijsbers
- 1 Maastricht University, Internal medicine, Tumor Immunology laboratory, Maastricht, The Netherlands
- Timo Olieslagers
- 4 Maastricht University, Department of Transplantation Immunology, Maastricht, The Netherlands
- Gerard Bos
- 1 Maastricht University, Internal medicine, Tumor Immunology laboratory, Maastricht, The Netherlands
- Lei Zheng
- 2 Nanfang Hospital, Guang Zhou, China
- Roel Klein Wolterink
- 1 Maastricht University, Internal medicine, Tumor Immunology laboratory, Maastricht, The Netherlands
- DOI
-
https://doi.org/10.1097/01.HS9.0000972360.43460.10
- Journal volume & issue
-
Vol. 7
p.
e4346010
WeChat QR code